Atlas Trials

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

Clinical trial NCT02022358 · TERMINATED

Trial details

NCT number
NCT02022358
Sponsor
University College, London
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
OsteosarcomaSpindle Cell Sarcoma of Bone
Start date
2007-07-01
Primary completion
2015-06-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.